Circulating Tumor Cells (CTC) Market Size | Share Report, 2032

Circulating Tumor Cells (CTC) Market - By Technology (CTC Detection & Enrichment, CTC Direct Detection), Application (Research, Clinical), Product (Devices or Systems, Kits & Assays), End-use (Research & Academic Institutes) & Forecast 2023 - 2032 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Circulating tumor cells (CTC) industry 3600&nbsp;synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Technology trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; Product trends

2.1.6&nbsp;&nbsp;&nbsp; Specimen trends

2.1.7&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing incidence of cancer cases

3.2.1.2&nbsp;&nbsp;&nbsp;Growing demand for early and rapid cancer diagnosis

3.2.1.3&nbsp;&nbsp;&nbsp;Advancements in CTCs detection technologies

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost associated with CTC analysis and detection methods

3.2.2.2&nbsp;&nbsp;&nbsp;Limited awareness and adoption

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By technology

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By product

3.3.4&nbsp;&nbsp;&nbsp; By specimen

3.3.5&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Market Size and Forecast, By Technology (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by technology

5.2&nbsp;&nbsp;&nbsp; CTC detection and enrichment method

5.2.1&nbsp;&nbsp;&nbsp; Immunocapture

5.2.1.1&nbsp;&nbsp;&nbsp;Positive selection

5.2.1.2&nbsp;&nbsp;&nbsp;Negative selection

5.2.2&nbsp;&nbsp;&nbsp; Size-based separation

5.2.2.1&nbsp;&nbsp;&nbsp;Membrane-based

5.2.2.2&nbsp;&nbsp;&nbsp;Microfluidic-based

5.2.3&nbsp;&nbsp;&nbsp; Density-based separation

5.2.4&nbsp;&nbsp;&nbsp; Combined methods

5.3&nbsp;&nbsp;&nbsp; CTC direct detection methods

5.3.1&nbsp;&nbsp;&nbsp; SERS

5.3.2&nbsp;&nbsp;&nbsp; Microscopy

5.3.3&nbsp;&nbsp;&nbsp; Other direct detection methods

5.4&nbsp;&nbsp;&nbsp; CTC analysis

Chapter 6&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Market Size and Forecast, By Application (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Research

6.2.1&nbsp;&nbsp;&nbsp; Cancer stem cell &amp; tumorogenesis research

6.2.2&nbsp;&nbsp;&nbsp; Drug / therapy development

6.3&nbsp;&nbsp;&nbsp; Clinical

6.3.1&nbsp;&nbsp;&nbsp; Screening and monitoring

6.3.2&nbsp;&nbsp;&nbsp; Risk assessment

Chapter 7&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Market Size and Forecast, By Product (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by product

7.2&nbsp;&nbsp;&nbsp; Devices or systems

7.3&nbsp;&nbsp;&nbsp; Kits &amp; assays

7.4&nbsp;&nbsp;&nbsp; Consumables

Chapter 8&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Market Size and Forecast, By Specimen (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by specimen

8.2&nbsp;&nbsp;&nbsp; Blood

8.3&nbsp;&nbsp;&nbsp; Bone marrow

8.4&nbsp;&nbsp;&nbsp; Other body fluids

Chapter 9&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Market Size and Forecast, By End-use (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

9.2&nbsp;&nbsp;&nbsp; Research and academic institutes

9.3&nbsp;&nbsp;&nbsp; Hospital and clinics

9.4&nbsp;&nbsp;&nbsp; Diagnostic centers

Chapter 10&nbsp;&nbsp;&nbsp;Circulating Tumor Cells Market Size and Forecast, By Region (USD Million)

10.1&nbsp;&nbsp;&nbsp; Key trends, by region

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; Japan

10.4.2&nbsp;&nbsp;&nbsp; China

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; MEA

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

11.2&nbsp;&nbsp;&nbsp; QIAGEN

11.3&nbsp;&nbsp;&nbsp; Precision for Medicine

11.4&nbsp;&nbsp;&nbsp; BIOCEPT, Inc.

11.5&nbsp;&nbsp;&nbsp; Fluxion Biosciences, Inc.

11.6&nbsp;&nbsp;&nbsp; Greiner Bio One International GmbH

11.7&nbsp;&nbsp;&nbsp; Ikonisys Inc.

11.8&nbsp;&nbsp;&nbsp; Miltenyi Biotec

11.9&nbsp;&nbsp;&nbsp; IVDiagnostics

11.10&nbsp;&nbsp;&nbsp; BioFluidica

11.11&nbsp;&nbsp;&nbsp; Biolidics Limited

11.12&nbsp;&nbsp;&nbsp; Creativ MicroTech, Inc.

11.13&nbsp;&nbsp;&nbsp; LungLife AI, Inc.

11.14&nbsp;&nbsp;&nbsp; Rarecells Diagnostics

11.15&nbsp;&nbsp;&nbsp; ScreenCell

11.16&nbsp;&nbsp;&nbsp; Sysmex Corporation

11.17&nbsp;&nbsp;&nbsp; STEMCELL Technologies, Inc. 
&nbsp;

Circulating Tumor Cells CTC Market

Get a free sample of this report